Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies
Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies
批准号:
10654215
负责人:
Thomas David Manes
金额:
$41.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2027-07-31
关键词:
Adoptive Cell TransfersAdoptive ImmunotherapyAdoptive TransferAffectAntigen PresentationAntigen-Presenting CellsAntigensAutoimmunityBlood VesselsCD8B1 geneCell Adhesion MoleculesCell LineCell surfaceCellsClinical TrialsCross PresentationCytoplasmDiseaseDual-role transvestismEndothelial CellsEndotheliumGene TransferHomingHumanImmunologyImplantIn VitroInfectionInfusion proceduresInterleukin-2KnowledgeLaboratoriesLigandsMediatingMedicalMemoryModelingMolecularMusOrganellesPatientsPatternPeptide/MHC ComplexPeripheralPhenotypePlayPopulationProcessProductionRegulatory T-LymphocyteRoleSignal InductionSignal TransductionSiteSurfaceT cell differentiationT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTherapeuticTissuesTreatment EfficacyTubular formationVascular Endothelial CellViral CancerVirus Diseasesallograft rejectionantigen-specific T cellsautoinflammatory diseasescancer immunotherapychemokinechimeric antigen receptorchimeric antigen receptor T cellscytokineeffector T cellexperimental studygenetic manipulationhuman migrationimmunodeficient mouse modelin vitro Modelin vivoin vivo Modelmigrationmonolayerreceptorrecruitresponsespecies differencesuccesstumor
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
Adoptive cell therapy (ACT) with activated and expanded T or CAR T cells may be used to treat infections or
tumors and ACT with T or CAR T regulatory cells are in clinical trials to control autoimmunity and allograft
rejection. Many but not all patients benefit. The success of ACT depends upon T cell homing to relevant tissue
sites. Normal circulating T effector memory or T regulatory cells can enter a tissue in response to their cognate
antigen being displayed on the surface of the local microvascular ECs in a process triggered by TCR and
modulated by costimulation. We hypothesize that antigen presentation by human endothelial cells (ECs)
will recruit adoptively transferred in vitro expanded T or CAR T effector and regulatory cells to specific
peripheral tissue sites in a process modulated by specific EC co-stimulators. In specific aim 1, we will
test this hypothesis in vitro in models we have developed using endothelial cell monolayers in flow chambers
to model in vivo conditions. We will expand our in vitro assys to include an examination of the effects that TCR-
induced transendothelial migration (TEM) has on the T cells at the single cell level. In the case of CAR T cells,
we will determine the most important costimulator receptor molecule motifs to be incorporated into the CAR for
optimal TEM. We will also determine if human ECs have the capacity to cross-present or be “cross-dressed” by
antigens allowing EC presentation of antigen to influence cancer immunotherapy. Finally, we will use a model
we developed for studying adoptively transferred human T cell responses to synthestic microvessels
assembled from human ECs, allowing genetic manipulation of the signals human ECs can provide. In aim 2
we will conduct similar experiments using T and CAR T regulatory cells. Successful completion of these aims
will provide important information for extending the range of patients who may benefit from ACT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human B cell infiltration into allografts: mechanisms and molecules
-
批准号:10043269
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2020
-
负责人:Thomas David Manes
-
依托单位:
Identification of human PECAM-1 receptor
-
批准号:8352827
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2012
-
负责人:Thomas David Manes
-
依托单位:
海外基金